Sprint Bioscience AB
XMUN:5JA1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sprint Bioscience AB
XMUN:5JA1
|
SE |
|
I
|
ITV PLC
OTC:ITVPY
|
UK |
|
Visteon Corp
NASDAQ:VC
|
US |
|
R
|
Re/Max Holdings Inc
F:2RM
|
US |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
US |
|
S
|
Shopify Inc
SWB:307
|
CA |
|
Unicharm Corp
OTC:UNCHF
|
JP |
|
C
|
China Securities Co Ltd
SWB:CS0
|
CN |
|
A
|
Aptiv PLC
F:D7A
|
IE |
|
N
|
Netweb Technologies India Ltd
NSE:NETWEB
|
IN |
|
D
|
Deutsche Post AG
XBER:DPW
|
DE |
|
MAP Aktif Adiperkasa Tbk PT
IDX:MAPA
|
ID |
|
E
|
EnerSys
XMUN:FDN
|
US |
|
D
|
DigitalOcean Holdings Inc
DUS:0SU
|
US |
|
T
|
TriMas Corp
NASDAQ:TRS
|
US |
|
NextCell Pharma AB
F:65G
|
SE |
|
F
|
Flotek Industries Inc
F:F2I
|
US |
|
G
|
Greif Inc
XBER:GR3
|
US |
|
T
|
Talanx AG
XBER:TLX
|
DE |
|
S
|
Sumitomo Realty & Development Co Ltd
OTC:SURDF
|
JP |
|
P
|
Pixelworks Inc
XMUN:PXLX
|
US |
Bankruptcy Probability
Sprint Bioscience AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sprint Bioscience AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
S
|
Sprint Bioscience AB
STO:SPRINT
|
289.1m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
450.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sprint Bioscience AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sprint Bioscience AB has no debt.
You can find a full breakdown on its Balance Sheet.
